450 related articles for article (PubMed ID: 28431580)
1. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.
Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW
Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580
[TBL] [Abstract][Full Text] [Related]
2. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
[TBL] [Abstract][Full Text] [Related]
3. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
Wong VC; Chen H; Ko JM; Chan KW; Chan YP; Law S; Chua D; Kwong DL; Lung HL; Srivastava G; Tang JC; Tsao SW; Zabarovsky ER; Stanbridge EJ; Lung ML
Int J Cancer; 2012 Jan; 130(1):83-95. PubMed ID: 21387288
[TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
7. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
[TBL] [Abstract][Full Text] [Related]
8. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma.
Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG
Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.
Zhu S; Li Y; Mi L; Zhang Y; Zhang L; Gong L; Han X; Yao L; Lan M; Chen Z; Zhang W
Dig Dis Sci; 2011 Dec; 56(12):3569-76. PubMed ID: 21789540
[TBL] [Abstract][Full Text] [Related]
11. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma.
Suzuki S; Yokobori T; Tanaka N; Sakai M; Sano A; Inose T; Sohda M; Nakajima M; Miyazaki T; Kato H; Kuwano H
Oncol Rep; 2012 Aug; 28(2):465-72. PubMed ID: 22641236
[TBL] [Abstract][Full Text] [Related]
12. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
[TBL] [Abstract][Full Text] [Related]
13. SDR9C7 promotes lymph node metastases in patients with esophageal squamous cell carcinoma.
Tang S; Gao L; Bi Q; Xu G; Wang S; Zhao G; Chen Z; Zheng X; Pan Y; Zhao L; Kang J; Yang G; Shi Y; Wu K; Gong T; Fan D
PLoS One; 2013; 8(1):e52184. PubMed ID: 23341893
[TBL] [Abstract][Full Text] [Related]
14. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma.
Ito T; Shimada Y; Kan T; David S; Cheng Y; Mori Y; Agarwal R; Paun B; Jin Z; Olaru A; Hamilton JP; Yang J; Abraham JM; Meltzer SJ; Sato F
Cancer Res; 2008 May; 68(9):3214-24. PubMed ID: 18451147
[TBL] [Abstract][Full Text] [Related]
15. The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.
Xie F; Ye L; Chen J; Wu N; Zhang Z; Yang Y; Zhang L; Jiang WG
J Transl Med; 2011 Jun; 9():95. PubMed ID: 21696600
[TBL] [Abstract][Full Text] [Related]
16. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
Liu Y; Qin Z; Yang K; Liu R; Xu Y
Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
[TBL] [Abstract][Full Text] [Related]
18. Upregulated ataxia-telangiectasia group D complementing gene correlates with poor prognosis in patients with esophageal squamous cell carcinoma.
Lai W; Zhao J; Zhang C; Cui D; Lin J; He Y; Zheng H; Wu X; Yang M
Dis Esophagus; 2013; 26(8):817-22. PubMed ID: 23020249
[TBL] [Abstract][Full Text] [Related]
19. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
[TBL] [Abstract][Full Text] [Related]
20. Expression of cytokeratin 34βE12 is a good indicator of tumor progression in esophageal squamous cell carcinoma.
Ono M; Kijima H; Seino H; Hakamada K; Igarashi Y
Biomed Res; 2012 Jun; 33(3):183-9. PubMed ID: 22790218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
